dc.creatorOiveira, Geraldo Gileno de Sá
dc.creatorHutchings, Patricia R
dc.creatorLydyard, Peter M
dc.date2017-08-11T13:12:58Z
dc.date2017-08-11T13:12:58Z
dc.date1994
dc.date.accessioned2023-09-26T20:44:18Z
dc.date.available2023-09-26T20:44:18Z
dc.identifierOLIVEIRA, G. G. S.; HUTCHINGS, P. R.; LYDYARD, P. M. Anti-CD4 treatment of NZB mice prevents the development of erythrocyte autoantibodies but hastens the appearance of anaemia. Immunology Letters, v. 39, p. 153-156, 1994.
dc.identifier0165-2478
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/20582
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8862967
dc.descriptionOliveira, Geraldo Gileno de Sá “Documento produzido em parceria ou por autor vinculado à Fiocruz, mas não consta à informação no documento”.
dc.descriptionBrazilian Council for Development of Research and Technology (CNPq.).
dc.descriptionNew Zealand Black (NZB) mice spontaneousl2,. develop autoimmune haemolytic anaemia as the result of production of autoantibodies to erythrocytes. We have recently shown that antibodies to CD4 prevent the development of erythrocyte autoantibodies in young mice (Coombs' negative). In spite of this inhibition of erythrocyte autoantibody production, the anti-CD4-treated mice show a precocious and severe anaemia. Balb, c mice treated with the same protocol do not develop anaemia. Our results suggest that er.~- thropoiesis in NZB mice is particularly sensitive to depletion of CD4 + T cells.
dc.formatapplication/pdf
dc.languageeng
dc.publisherElsevier
dc.rightsopen access
dc.subjectAnemia hemolitica
dc.subjectRatos
dc.subjectAntigeno CD4
dc.subjectAnimais
dc.subjectNew Zealand black mouse
dc.subjectAnaemia
dc.subjectAntibody to CD4
dc.subjectAnimals
dc.titleAnti-CD4 treatment of NZB mice prevents the development of erythrocyte autoantibodies but hastens the appearance of anaemia.
dc.typeArticle


Este ítem pertenece a la siguiente institución